Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |